XML 19 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Beginning Balance (in shares) at Sep. 30, 2023   13,950    
Beginning balance at Sep. 30, 2023 $ 102,439 $ 14 $ 99,974 $ 2,451
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Expense related to director restricted stock units 80   80  
Expense related to employee stock-based compensation 540   540  
Exercise of stock options (in shares)   220    
Exercise of stock options 261   261  
Common stock surrendered for the exercise of stock options (in shares)   (65)    
Common stock surrendered for the exercise of stock options (669)   (669)  
Net income 2,151     2,151
Ending Balance (in shares) at Dec. 31, 2023   14,105    
Ending balance at Dec. 31, 2023 $ 104,802 $ 14 100,186 4,602
Beginning Balance (in shares) at Sep. 30, 2024 14,386 14,386    
Beginning balance at Sep. 30, 2024 $ 110,132 $ 14 100,270 9,848
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Expense related to director restricted stock units 180   180  
Expense related to employee stock-based compensation $ 13   13  
Exercise of stock options (in shares) 0      
Net income $ 1,115     1,115
Ending Balance (in shares) at Dec. 31, 2024 14,386 14,386    
Ending balance at Dec. 31, 2024 $ 111,440 $ 14 $ 100,463 $ 10,963